| Literature DB >> 12354380 |
Haifa Jabara1, Dhafer Laouini, Erdyni Tsitsikov, Emiko Mizoguchi, Atul Bhan, Emanuela Castigli, Fatma Dedeoglu, Vadim Pivniouk, Scott Brodeur, Raif Geha.
Abstract
To define the role of TRAF proteins in CD40-dependent isotype switching in B cells, we introduced wild-type (WT) and mutant CD40 transgenes that lacked the binding motifs for TRAF6 (CD40deltaTRAF6), TRAF2 and TRAF3 (CD40deltaTRAF2/3), or both (CD40deltaTRAFs) into B cells of CD40(-/-) mice. The in vivo isotype switch defect in CD40(-/-) mice was fully corrected by WT and CD40deltaTRAF6, partially by CD40deltaTRAF2/3, and not at all by CD40deltaTRAFs transgenes. CD40-mediated isotype switching, proliferation, and activation of p38, JNK, and NFkappaB in B cells were normal in WT and CD40deltaTRAF6 mice, severely impaired in CD40deltaTRAF2/3, and absent in CD40deltaTRAFs mice. These results suggest that binding to TRAF2 and/or TRAF3 but not TRAF6 is essential for CD40 isotype switching and activation in B cells.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12354380 DOI: 10.1016/s1074-7613(02)00394-1
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745